303 related articles for article (PubMed ID: 29506502)
1. Effects of subclinical inflammation on C-reactive protein and haptoglobin levels as well as specific humoral immunity in dogs vaccinated against canine distemper and parvovirus.
Romiszewski P; Kostro K; Lisiecka U
BMC Vet Res; 2018 Mar; 14(1):70. PubMed ID: 29506502
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study.
Vila Nova B; Cunha E; Sepúlveda N; Oliveira M; São Braz B; Tavares L; Almeida V; Gil S
BMC Vet Res; 2018 Nov; 14(1):348. PubMed ID: 30445957
[TBL] [Abstract][Full Text] [Related]
3. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
4. Thoughts on vaccination protocols.
Petzel B
J Am Vet Med Assoc; 2000 Nov; 217(10):1459. PubMed ID: 11128531
[No Abstract] [Full Text] [Related]
5. Thoughts on vaccination protocols.
McLaughlin MA
J Am Vet Med Assoc; 2000 Nov; 217(10):1458-9. PubMed ID: 11128530
[No Abstract] [Full Text] [Related]
6. Clinical and serological response of wild dogs (Lycaon pictus) to vaccination against canine distemper, canine parvovirus infection and rabies.
van Heerden J; Bingham J; van Vuuren M; Burroughs RE; Stylianides E
J S Afr Vet Assoc; 2002 Mar; 73(1):8-12. PubMed ID: 12088076
[TBL] [Abstract][Full Text] [Related]
7. Seroconversion of puppies to canine parvovirus and canine distemper virus: a comparison of two combination vaccines.
Coyne MJ
J Am Anim Hosp Assoc; 2000; 36(2):137-42. PubMed ID: 10730624
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
[TBL] [Abstract][Full Text] [Related]
9. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
Litster A; Nichols J; Volpe A
Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
[TBL] [Abstract][Full Text] [Related]
11. Challenge studies for registration of canine core vaccines: is it time to update the European Pharmacopeia?
Decaro N; Elia G; Buonavoglia C
Vet Microbiol; 2020 May; 244():108659. PubMed ID: 32402341
[No Abstract] [Full Text] [Related]
12. Application of a dot enzyme-linked immunosorbent assay for evaluation of the immune status to canine parvovirus and distemper virus in adult dogs before revaccination.
Waner T; Mazar S; Keren-Kornblatt E
J Vet Diagn Invest; 2006 May; 18(3):267-70. PubMed ID: 16789715
[TBL] [Abstract][Full Text] [Related]
13. Vaccination at different anatomic sites induces different levels of the immune responses.
Jin H; Xu Y; Shi F; Hu S
Res Vet Sci; 2019 Feb; 122():50-55. PubMed ID: 30453180
[TBL] [Abstract][Full Text] [Related]
14. Long-lived immunity to canine core vaccine antigens in UK dogs as assessed by an in-practice test kit.
Killey R; Mynors C; Pearce R; Nell A; Prentis A; Day MJ
J Small Anim Pract; 2018 Jan; 59(1):27-31. PubMed ID: 29087557
[TBL] [Abstract][Full Text] [Related]
15. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H
Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693
[TBL] [Abstract][Full Text] [Related]
17. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines.
Bergman JG; Muniz M; Sutton D; Fensome R; Ling F; Paul G
Vet Rec; 2006 Nov; 159(22):733-6. PubMed ID: 17127756
[TBL] [Abstract][Full Text] [Related]
18. Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper.
Chandran D; Shahana PV; Rani GS; Sugumar P; Shankar CR; Srinivasan VA
Vaccine; 2009 Dec; 28(1):132-9. PubMed ID: 19818723
[TBL] [Abstract][Full Text] [Related]
19. Canine parvovirus vaccination.
Atkinson M
Vet Rec; 2006 Dec 23-30; 159(26):895; author reply 895-6. PubMed ID: 17189604
[No Abstract] [Full Text] [Related]
20. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
